157 related articles for article (PubMed ID: 35299662)
1. Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway.
Yu X; Meng Z; Fang T; Liu X; Cheng Y; Xu L; Liu X; Li X; Xue M; Li T; Sun B; Chen L
Front Physiol; 2022; 13():817542. PubMed ID: 35299662
[TBL] [Abstract][Full Text] [Related]
2. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
[TBL] [Abstract][Full Text] [Related]
3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
4. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
5. Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway
Li T; Fang T; Xu L; Liu X; Li X; Xue M; Yu X; Sun B; Chen L
Front Pharmacol; 2020; 11():622153. PubMed ID: 33551821
[No Abstract] [Full Text] [Related]
6. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.
Lee J; Hong SW; Kim MJ; Lim YM; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY
Endocrinol Metab (Seoul); 2024 Feb; 39(1):98-108. PubMed ID: 38171209
[TBL] [Abstract][Full Text] [Related]
7. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
8. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway.
Meng Z; Liu X; Li T; Fang T; Cheng Y; Han L; Sun B; Chen L
Int Immunopharmacol; 2021 May; 94():107492. PubMed ID: 33647823
[TBL] [Abstract][Full Text] [Related]
9. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Park JE; Han JS
Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice.
Lu YH; Chang YP; Li T; Han F; Li CJ; Li XY; Xue M; Cheng Y; Meng ZY; Han Z; Sun B; Chen LM
Int J Biol Sci; 2020; 16(3):529-542. PubMed ID: 32015688
[TBL] [Abstract][Full Text] [Related]
11. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
12. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
Yuan HD; Piao GC
Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525
[TBL] [Abstract][Full Text] [Related]
13. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
[TBL] [Abstract][Full Text] [Related]
14. L-Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice.
Wang Y; Guan Y; Xue L; Liu J; Yang Z; Nie C; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Li Y; Wang L
Food Funct; 2021 Mar; 12(4):1745-1756. PubMed ID: 33502423
[TBL] [Abstract][Full Text] [Related]
15. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice.
Li YY; Yu LF; Zhang LN; Qiu BY; Su MB; Wu F; Chen DK; Pang T; Gu M; Zhang W; Ma WP; Jiang HW; Li JY; Nan FJ; Li J
Toxicol Appl Pharmacol; 2013 Dec; 273(2):325-34. PubMed ID: 24055643
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells.
Yuan HD; Kim DY; Quan HY; Kim SJ; Jung MS; Chung SH
Chem Biol Interact; 2012 Jan; 195(1):35-42. PubMed ID: 22062806
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
18. C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes.
Ren Z; Xie Z; Cao D; Gong M; Yang L; Zhou Z; Ou Y
Food Funct; 2018 May; 9(5):2829-2839. PubMed ID: 29693104
[TBL] [Abstract][Full Text] [Related]
19. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
[TBL] [Abstract][Full Text] [Related]
20. Effect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes.
Kim JW; Lee YJ; You YH; Moon MK; Yoon KH; Ahn YB; Ko SH
J Cell Biochem; 2019 May; 120(5):8534-8546. PubMed ID: 30474134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
